Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: kamat am. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Intravesical therapy for bladder cancer.
Kamat AM, Lamm DL. Kamat AM, et al. Urology. 2000 Feb;55(2):161-8. doi: 10.1016/s0090-4295(99)00463-x. Urology. 2000. PMID: 10688071 Review. No abstract available.
Immunotherapy for bladder cancer.
Kamat AM, Lamm DL. Kamat AM, et al. Curr Urol Rep. 2001 Feb;2(1):62-9. doi: 10.1007/s11934-001-0027-7. Curr Urol Rep. 2001. PMID: 12084297 Review.
Chemoprevention of superficial bladder cancer.
Kamat AM. Kamat AM. Expert Rev Anticancer Ther. 2003 Dec;3(6):799-808. doi: 10.1586/14737140.3.6.799. Expert Rev Anticancer Ther. 2003. PMID: 14686702 Review.
Focus on bladder cancer.
Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B. Dinney CP, et al. Among authors: kamat am. Cancer Cell. 2004 Aug;6(2):111-6. doi: 10.1016/j.ccr.2004.08.002. Cancer Cell. 2004. PMID: 15324694 Free article. Review. No abstract available.
Current state of immunotherapy for bladder cancer.
Kassouf W, Kamat AM. Kassouf W, et al. Among authors: kamat am. Expert Rev Anticancer Ther. 2004 Dec;4(6):1037-46. doi: 10.1586/14737140.4.6.1037. Expert Rev Anticancer Ther. 2004. PMID: 15606331 Review.
520 results